Literature DB >> 9050237

Role of the Ca(2+)-sensing receptor in divalent mineral ion homeostasis.

S C Hebert1, E M Brown, H W Harris.   

Abstract

The divalent mineral cations Ca2+ and Mg2+ play many and diverse roles both in the function of cells and in extracellular processes. The metabolism of these cations is a complex process involving the coordinated function of several organ systems and endocrine glands. A recently cloned G-protein-coupled receptor responds to extracellular calcium concentration (Ca2+0-sensing receptor, CaSR) and mediates several of the known effects of Ca2+0 on parathyroid and renal function. The CaSR, which is also expressed in a number of other tissues including thyroidal C-cells, brain and gastrointestinal tract, may function as a Ca2+0 sensor in these tissues as well. Thus, Ca2+0 is a first messenger (or hormone) which, via CaSR-mediated activation of second messenger systems (e.g. phospholipases C and A2, cyclic AMP) leads to altered function of these cells. Several mutations in the human CaSR gene have been identified and shown to cause three inherited diseases of calcium homeostasis, clearly implicating the CaSR as an important component of the homeostatic mechanism for divalent mineral ions. Ca2+ and Mg2+ losses from the body are regulated by altering the urinary excretion of these divalent cations. The localization of the CaSR transcripts and protein in the kidney not only provides a basis for a direct Ca2+0 (or Mg2+0)-mediated regulation of Ca2+ (and Mg2+) excretion but also suggests a functional link between divalent mineral and water metabolism. In the kidney, the thick ascending limb of Henle (TAL) plays crucial roles in regulating both divalent mineral reabsorption and urine concentration. Recent studies have suggested models whereby extracellular Ca2+, via the CaSR expressed in the TAL as well as in the collecting duct system, modulates both Ca2+ 0 and Mg2+ 0 as well as water reabsorbtion. When taken together, these studies suggest that the CaSR not only provides the primary mechanism for Ca2+ 0-mediated regulation of parathyroid hormone secretion from parathyroid glands but also for direct modulation of renal divalent mineral excretion and urinary concentrating ability. These latter functions may furnish a mechanism for integrating and balancing water and divalent cation losses that minimizes the risk of urinary tract stone formation. This mechanism can explain hypercalcemia-mediated polyuria (diabetes insipidus).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9050237     DOI: 10.1242/jeb.200.2.295

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  40 in total

1.  Nephrolithiasis: site of the initial solid phase.

Authors:  David A Bushinsky
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 2.  Is the calcium receptor a molecular target for the actions of strontium on bone?

Authors:  Edward M Brown
Journal:  Osteoporos Int       Date:  2003-03-12       Impact factor: 4.507

3.  Secondary nephrogenic diabetes insipidus as a complication of inherited renal diseases.

Authors:  D Bockenhauer; W van't Hoff; M Dattani; A Lehnhardt; M Subtirelu; F Hildebrandt; D G Bichet
Journal:  Nephron Physiol       Date:  2010-08-20

Review 4.  The role of vitamin D in the endocrinology controlling calcium homeostasis.

Authors:  James C Fleet
Journal:  Mol Cell Endocrinol       Date:  2017-04-09       Impact factor: 4.102

Review 5.  Kidney stone disease.

Authors:  Fredric L Coe; Andrew Evan; Elaine Worcester
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 6.  Role of renal transporters and novel regulatory interactions in the TAL that control blood pressure.

Authors:  Lesley A Graham; Anna F Dominiczak; Nicholas R Ferreri
Journal:  Physiol Genomics       Date:  2017-04-07       Impact factor: 3.107

7.  Tumor necrosis factor-alpha induces renal cyclooxygenase-2 expression in response to hypercalcemia.

Authors:  Sailaja Battula; Shoujin Hao; Paulina L Pedraza; Charles T Stier; Nicholas R Ferreri
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-07-16       Impact factor: 3.072

Review 8.  Claudins and the kidney.

Authors:  Alan S L Yu
Journal:  J Am Soc Nephrol       Date:  2014-06-19       Impact factor: 10.121

Review 9.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

10.  Salt and acid-base metabolism in claudin-16 knockdown mice: impact for the pathophysiology of FHHNC patients.

Authors:  Nina Himmerkus; Qixian Shan; Boeren Goerke; Jianghui Hou; Daniel A Goodenough; Markus Bleich
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.